MEDIROM Healthcare Technologies reported net profit of JPY115 million for FY2023, despite significant investment in healthcare technology systems. Revenue slightly decreased 1.8% to JPY6.83 billion, while Adjusted EBITDA reached JPY306 million with a 4.5% margin.The Relaxation Salon segment saw 1.5% revenue growth to JPY6.06 billion, driven by increased sales per customer to JPY6,852. The company sold 30 salons to investors in 2023 under its sale-and-outsource model. Digital Preventative Healthcare revenue declined 48.1% to JPY200 million due to delays in REMONY system development.The company maintained profitability while advancing its healthcare technology initiatives, including the launch of REMONY Monitoring System. As of May 2024, MEDIROM operates 307 relaxation salons across Japan and has contracts with 81 corporate insurance associations for its Lav health guidance program, serving over 7,200 users.

MEDIROM Healthcare Technologies reported net profit of JPY115 million for FY2023, despite significant investment in healthcare technology systems. Revenue slightly decreased 1.8% to JPY6.83 billion, while Adjusted EBITDA reached JPY306 million with a 4.5% margin.The Relaxation Salon segment saw 1.5% revenue growth to JPY6.06 billion, driven by increased sales per customer to JPY6,852. The company sold 30 salons to investors in 2023 under its sale-and-outsource model. Digital Preventative Healthcare revenue declined 48.1% to JPY200 million due to delays in REMONY system development.The company maintained profitability while advancing its healthcare technology initiatives, including the launch of REMONY Monitoring System. As of May 2024, MEDIROM operates 307 relaxation salons across Japan and has contracts with 81 corporate insurance associations for its Lav health guidance program, serving over 7,200 users.